tradingkey.logo
tradingkey.logo
Search

Health Canada Authorizes Lilly's Kisunla™ (Donanemab), A New Treatment For Early Alzheimer's Disease

ReutersMay 4, 2026 12:09 PM
facebooktwitterlinkedin
View all comments0

- Eli Lilly and Co LLY.N:

  • HEALTH CANADA AUTHORIZES LILLY'S KISUNLA™ (DONANEMAB), A NEW TREATMENT FOR EARLY ALZHEIMER'S DISEASE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI